What is Cytek Biosciences, Inc.'s AOCI?

Cytek Biosciences, Inc. (CTKB) reported AOCI of $2.37M in Q1 2026.

How has Cytek Biosciences, Inc.'s AOCI changed year-over-year?

Cytek Biosciences, Inc.'s AOCI increased by 489.0% year-over-year, from -$609K to $2.37M.

What is the long-term trend for Cytek Biosciences, Inc.'s AOCI?

Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s AOCI has grown at a 103.0% compound annual growth rate (CAGR), from $65K to $2.24M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Cytek Biosciences, Inc. CTKB AOCI

AOCI at other companies

Becton, Dickinson and CompanyBDX

-$1.76B-2.8%

Thermo Fisher ScientificTMO

-$2.5B-6.6%

DanaherDHR

-$593M+63.2%

Fulgent Genetics, Inc.FLGT

$4.54M+4.6%

10x Genomics, Inc.TXG

$114K+131%

TEC

Bio-TechneTECH

-$66.86M+18.5%

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s AOCI?: Cytek Biosciences, Inc. (CTKB) reported AOCI of $2.37M in Q1 2026.
How has Cytek Biosciences, Inc.'s AOCI changed year-over-year?: Cytek Biosciences, Inc.'s AOCI increased by 489.0% year-over-year, from -$609K to $2.37M.
What is the long-term trend for Cytek Biosciences, Inc.'s AOCI?: Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s AOCI has grown at a 103.0% compound annual growth rate (CAGR), from $65K to $2.24M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.